Story perspectives

Dana-Farber Settles $15M Over Misrepresented NIH Research Data

12/17/2025

Summary

Story summary

Dana-Farber Cancer Institute settled for $15 million over allegations that data from National Institutes of Health (NIH)-funded research were misrepresented, including reused and altered images.
The Department of Justice stated that fraud in scientific research undermines public trust and emphasized the need for integrity.
Dana-Farber admitted insufficient oversight and has started measures to enhance research integrity.
CEO Benjamin Ebert reaffirmed the institute's commitment to maintaining high standards in research practices.

1 of 1

Story summary

Dana-Farber Cancer Institute settled for $15 million over allegations that data from National Institutes of Health (NIH)-funded research were misrepresented, including reused and altered images.
The Department of Justice stated that fraud in scientific research undermines public trust and emphasized the need for integrity.
Dana-Farber admitted insufficient oversight and has started measures to enhance research integrity.
CEO Benjamin Ebert reaffirmed the institute's commitment to maintaining high standards in research practices.